載入...
A Phase II Study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia
Novel therapies for the treatment of acute myeloid leukemia are required to overcome disease resistance and to provide potentially less toxic therapies for older adults. Prior clinical trials involving patients with non-small cell lung cancer have demonstrated the safety and biologic activity of the...
Na minha lista:
| 發表在: | Leuk Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4860003/ https://ncbi.nlm.nih.gov/pubmed/24522247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2013.10.026 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|